The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Safe Desmopressin Administration - EP2442821

The patent EP2442821 was granted to Acerus Pharmaceuticals USA on Feb 12, 2025. The application was originally filed on Jun 15, 2010 under application number EP10790053A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2442821

ACERUS PHARMACEUTICALS USA
Application Number
EP10790053A
Filing Date
Jun 15, 2010
Status
Patent Maintained As Amended
Jan 10, 2025
Publication Date
Feb 12, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

FERRINGMar 12, 2018PRINSWITHDRAWN

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2008299079
INTERNATIONAL-SEARCH-REPORTUS2009005432
INTERNATIONAL-SEARCH-REPORTUS6605060
OPPOSITIONUS6227413
OPPOSITIONUS7112561
OPPOSITIONUS7182226
OPPOSITIONUS7244703
OPPOSITIONUS7405203
OPPOSITIONUS9539302
OPPOSITIONWO2010075266
OPPOSITIONWO9501183
SEARCHUS2009005432
SEARCHUS2009035260
SEARCHUS5731303
SEARCHWO2009003199
SEARCHWO2010075266
SEARCHWO2010075327

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents